Market Cap

Hanmi Pharm. Co. Ltd Market Capitalization:

₩4.505 Trillion

KRW as of Jan. 1, 2024

US$3.48 Billion

business Hanmi Pharm. Co. Ltd Company Profile

Hanmi Pharm. Co. Ltd Main Stock Listing

KRX: 128940

Market Capitalization History of Hanmi Pharm. Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Hanmi Pharm. Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₩4.505 T 31.82%
Jan. 1, 2023 ₩3.418 T 7.09%
Jan. 1, 2022 ₩3.191 T -34.22%
Jan. 1, 2021 ₩4.852 T 39.02%
Jan. 1, 2020 ₩3.490 T -33.96%
Jan. 1, 2019 ₩5.284 T -25.85%
Jan. 1, 2018 ₩7.126 T 126.24%
Jan. 1, 2017 ₩3.150 T -58.92%
Jan. 1, 2016 ₩7.667 T 631.10%
Jan. 1, 2015 ₩1.049 T -23.26%
Jan. 1, 2014 ₩1.366 T 3.93%
Jan. 1, 2013 ₩1.315 T 121.97%
Jan. 1, 2012 ₩592.35 B -9.80%
Jan. 1, 2011 ₩656.69 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Hanmi Pharm. Co. Ltd Categories

South Korea languages Healthcare languages Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Stocks & Indices

Hanmi Pharm. Co. Ltd has the following listings and related stock indices.


Stock: KRX: 128940

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.